These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 26905278)
1. Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study. Rupérez M; González R; Mombo-Ngoma G; Kabanywanyi AM; Sevene E; Ouédraogo S; Kakolwa MA; Vala A; Accrombessi M; Briand V; Aponte JJ; Manego Zoleko R; Adegnika AA; Cot M; Kremsner PG; Massougbodji A; Abdulla S; Ramharter M; Macete E; Menéndez C PLoS Med; 2016 Feb; 13(2):e1001964. PubMed ID: 26905278 [TBL] [Abstract][Full Text] [Related]
2. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069 [TBL] [Abstract][Full Text] [Related]
3. Mefloquine for preventing malaria in pregnant women. González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063 [TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy. Sicuri E; Fernandes S; Macete E; González R; Mombo-Ngoma G; Massougbodgi A; Abdulla S; Kuwawenaruwa A; Katana A; Desai M; Cot M; Ramharter M; Kremsner P; Slustker L; Aponte J; Hanson K; Menéndez C PLoS One; 2015; 10(4):e0125072. PubMed ID: 25915616 [TBL] [Abstract][Full Text] [Related]
5. Mefloquine for preventing malaria in pregnant women. González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761 [TBL] [Abstract][Full Text] [Related]
6. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial. González R; Mombo-Ngoma G; Ouédraogo S; Kakolwa MA; Abdulla S; Accrombessi M; Aponte JJ; Akerey-Diop D; Basra A; Briand V; Capan M; Cot M; Kabanywanyi AM; Kleine C; Kremsner PG; Macete E; Mackanga JR; Massougbodgi A; Mayor A; Nhacolo A; Pahlavan G; Ramharter M; Rupérez M; Sevene E; Vala A; Zoleko-Manego R; Menéndez C PLoS Med; 2014 Sep; 11(9):e1001733. PubMed ID: 25247709 [TBL] [Abstract][Full Text] [Related]
7. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial. Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921 [TBL] [Abstract][Full Text] [Related]
8. Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability. Briand V; Escolano S; Journot V; Massougbodji A; Cot M; Tubert-Bitter P Am J Trop Med Hyg; 2015 Aug; 93(2):300-4. PubMed ID: 26055735 [TBL] [Abstract][Full Text] [Related]
9. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial. González R; Desai M; Macete E; Ouma P; Kakolwa MA; Abdulla S; Aponte JJ; Bulo H; Kabanywanyi AM; Katana A; Maculuve S; Mayor A; Nhacolo A; Otieno K; Pahlavan G; Rupérez M; Sevene E; Slutsker L; Vala A; Williamsom J; Menéndez C PLoS Med; 2014 Sep; 11(9):e1001735. PubMed ID: 25247995 [TBL] [Abstract][Full Text] [Related]
10. Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy. Huijben S; Macete E; Mombo-Ngoma G; Ramharter M; Kariuki S; Desai M; Shi YP; Mwangoka G; Massougbodji A; Cot M; Ndam NT; Uberegui E; Gupta H; Cisteró P; Aponte JJ; González R; Menéndez C; Mayor A J Infect Dis; 2020 Jan; 221(2):293-303. PubMed ID: 31677349 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial. Anvikar AR; Kuepfer I; Mishra V; Bruce J; Arya T; Mishra DR; Mohanty S; Mohanty R; Srivastava B; Sharma S; Mishra N; Greenwood B; Chandramohan D; Valecha N Malar J; 2018 Jul; 17(1):246. PubMed ID: 29973212 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial. Kimani J; Phiri K; Kamiza S; Duparc S; Ayoub A; Rojo R; Robbins J; Orrico R; Vandenbroucke P PLoS One; 2016; 11(6):e0157045. PubMed ID: 27326859 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine. Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300 [TBL] [Abstract][Full Text] [Related]
15. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria. Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228 [TBL] [Abstract][Full Text] [Related]